Perspectives on Enquiry & Evidence

Scientists at Cytel recently published a paper in the Journal of the American Medical Association (JAMA). Among the..

Earlier this month, my colleagues at Cytel Canada published a paper in JCO Clinical Cancer Informatics, offering a..

Recent years have witnessed improving survival outcomes for those struggling with a range of common kidney cancers...

COVID-19 has transformed the pharmaceutical industry in a manner that few could have predicted only a year ago. One of..

As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation..

Virtual ISPOR 2020, held November 16 to 19, presented new opportunities for scientific interaction amongst HEOR..

  As a part of Cytel’s "New Horizons Webinar Series", Alind Gupta, Senior Data Scientist, presents case studies from..

Cytel and Ingress Health (now a Cytel company) will be contributing to a range of events at Virtual ISPOR EUROPE 2020,..

Platform trials are a new type of clinical trials where multiple interventions can be evaluated simultaneously against..